Francoise Jeanne Gellibert

Title: The Innovative Mind of Francoise Jeanne Gellibert

Introduction: Francoise Jeanne Gellibert, based in Les Ulis, France, is a distinguished inventor with a remarkable portfolio of four patents. Her work primarily focuses on pharmaceuticals, where she has developed novel compounds with significant therapeutic potential.

Latest Patents: Among her latest patents, two stand out for their innovative approaches. The first patent involves "Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitors," which presents novel compounds of formula (I) along with their salts and pharmaceutical compositions for therapeutic use. The second patent features "Phenyloxyalkanonic acid derivatives as hPPAR activators," detailing compounds of formula (I) and their pharmaceutically acceptable salts, solvates, or hydrolysable esters.

Career Highlights: Throughout her career, Gellibert has made substantial contributions to the pharmaceutical industry. She has worked with prominent companies such as GlaxoSmithKline LLC and Lilly Icos LLC, where she has honed her skills in drug development and innovation.

Collaborations: Gellibert has collaborated with notable professionals in her field, including Anne Marie Jeanne Bouillot and Frederic G Donche. These partnerships have undoubtedly enriched her research and expanded her network within the pharmaceutical community.

Conclusion: Francoise Jeanne Gellibert exemplifies an enterprising spirit, contributing valuable inventions to the field of pharmaceuticals. Her innovative work in developing new compounds has the potential to lead to significant advancements in therapeutic treatments, solidifying her reputation as a leading inventor in the industry.